196 related articles for article (PubMed ID: 34370741)
1. Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells.
Astarita EM; Maloney SM; Hoover CA; Berkeley BJ; VanKlompenberg MK; Nair TM; Prosperi JR
PLoS One; 2021; 16(8):e0255738. PubMed ID: 34370741
[TBL] [Abstract][Full Text] [Related]
2. RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage.
Haynes BM; Cunningham K; Shekhar MPV
BMC Cancer; 2022 Oct; 22(1):1073. PubMed ID: 36258187
[TBL] [Abstract][Full Text] [Related]
3. APC selectively mediates response to chemotherapeutic agents in breast cancer.
VanKlompenberg MK; Bedalov CO; Soto KF; Prosperi JR
BMC Cancer; 2015 Jun; 15():457. PubMed ID: 26049416
[TBL] [Abstract][Full Text] [Related]
4. CCAAT enhancer binding protein delta activates vesicle associated membrane protein 3 transcription to enhance chemoresistance and extracellular PD-L1 expression in triple-negative breast cancer.
Zhao Y; Yu Y; Li X; Guo A
J Exp Clin Cancer Res; 2024 Apr; 43(1):115. PubMed ID: 38627816
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of SASS6 reduces growth of MDA‑MB‑231 triple‑negative breast cancer cells through arrest of the cell cycle at the G2/M phase.
Du L; Jing J; Wang Y; Xu X; Sun T; Shi Y; Wang W; Tian B; Han C; Zhao X; Chang H
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907854
[TBL] [Abstract][Full Text] [Related]
6. CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA.
Yang X; Zhao L; Pei J; Wang Z; Zhang J; Wang B
Breast Cancer Res Treat; 2020 Aug; 183(1):71-82. PubMed ID: 32601971
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis.
Zhao PW; Cui JX; Wang XM
Pharmacogenomics J; 2024 Feb; 24(2):5. PubMed ID: 38378770
[TBL] [Abstract][Full Text] [Related]
8. circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.
Zheng SR; Huang QD; Zheng ZH; Zhang ZT; Guo GL
J Biochem; 2021 Jul; 169(5):601-611. PubMed ID: 33481008
[TBL] [Abstract][Full Text] [Related]
9. A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line.
Lasham A; Mehta SY; Fitzgerald SJ; Woolley AG; Hearn JI; Hurley DG; Ruza I; Algie M; Shelling AN; Braithwaite AW; Print CG
Int J Cancer; 2016 Sep; 139(5):1157-70. PubMed ID: 27072400
[TBL] [Abstract][Full Text] [Related]
10. Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.
Speyer CL; Bukhsh MA; Jafry WS; Sexton RE; Bandyopadhyay S; Gorski DH
Breast Cancer Res Treat; 2017 Nov; 166(2):407-419. PubMed ID: 28780701
[TBL] [Abstract][Full Text] [Related]
11. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
[TBL] [Abstract][Full Text] [Related]
13. Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cells.
Jaiswal AS; Narayan S
J Cell Biochem; 2004 Oct; 93(2):345-57. PubMed ID: 15368361
[TBL] [Abstract][Full Text] [Related]
14. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
[TBL] [Abstract][Full Text] [Related]
15. Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.
Kumari S; Mohan MG; Shailender G; Badana AK; Malla RR
J Cell Biochem; 2019 Oct; 120(10):18104-18116. PubMed ID: 31172606
[TBL] [Abstract][Full Text] [Related]
16. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
Jaiswal AS; Multani AS; Pathak S; Narayan S
Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
[TBL] [Abstract][Full Text] [Related]
18. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
[TBL] [Abstract][Full Text] [Related]
19. MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest.
Wang Y; Wu N; Zhang J; Wang H; Men X
Onco Targets Ther; 2020; 13():4089-4097. PubMed ID: 32494162
[TBL] [Abstract][Full Text] [Related]
20. Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.
Dikovskaya D; Schiffmann D; Newton IP; Oakley A; Kroboth K; Sansom O; Jamieson TJ; Meniel V; Clarke A; Näthke IS
J Cell Biol; 2007 Jan; 176(2):183-95. PubMed ID: 17227893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]